Astera Labs Board Member's Stock Moves Signal Portfolio Restructuring
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Astera Labs director Bethany Mayer executed multiple transactions on June 24-26, 2025, including both sales and transfers of common stock:
- Sold 686 shares on June 24 through a pre-planned Rule 10b5-1 trading plan at weighted average prices between $86.81-$88.50 per share
- Transferred 839 shares on June 26 to The Jantzen/Mayer Family 2002 Trust for no consideration
Following these transactions, Mayer directly owns 5,399 shares and indirectly owns 839 shares through the Trust. The sales were executed automatically under a Rule 10b5-1 plan established on November 25, 2024. As trustee of the Family Trust, Mayer disclaims beneficial ownership of the transferred shares except for any pecuniary interest.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 686 shares ($60,003)
Net Sell
5 txns
Insider
Mayer Bethany
Role
Director
Sold
686 shs ($60K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Gift | Common Stock | 839 | $0.00 | -- |
| Gift | Common Stock | 839 | $0.00 | -- |
| Sale | Common Stock | 261 | $86.8098 | $23K |
| Sale | Common Stock | 312 | $87.6454 | $27K |
| Sale | Common Stock | 113 | $88.5011 | $10K |
Holdings After Transaction:
Common Stock — 5,399 shares (Direct);
Common Stock — 839 shares (Indirect, By Trust)
Footnotes (1)
- The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 25, 2024. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $86.3300 to $87.2950, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $87.3550 to $88.0900, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $88.4600 to $88.5400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. On June 26, 2025, the Reporting Person transferred 839 shares of Common Stock to The Jantzen/Mayer Family 2002 Trust (the "Trust") for no consideration. These shares are owned directly by the Trust, of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of her pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
FAQ
What was the price range of ALAB stock sales by Bethany Mayer on June 24, 2025?
The ALAB stock sales occurred across three price ranges: $86.33 to $87.29, $87.35 to $88.09, and $88.46 to $88.54, with weighted average prices of $86.81, $87.65, and $88.50 respectively.
Was ALAB Director Mayer's stock sale part of a pre-planned trading arrangement?
Yes, the sales were executed automatically pursuant to a Rule 10b5-1 trading plan that Director Bethany Mayer had previously adopted on November 25, 2024.